Filtered By:
Source: Current Vascular Pharmacology
Condition: Thrombosis

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 49 results found since Jan 2013.

Efficacy and safety of direct oral anticoagulants in the treatment of left ventricular thrombus after acute anterior myocardial infarction in patients who underwent percutaneous coronary intervention
CONCLUSIONS: DOACs appears to be a suitable alternative to warfarin for the management of LVT post STEMI, especially in patients who are intolerant to warfarin.PMID:36200193 | DOI:10.2174/1570161120666221003104821
Source: Current Vascular Pharmacology - October 6, 2022 Category: Drugs & Pharmacology Authors: Jing Liang Zhijian Wang Yujie Zhou Hua Shen Meng Chai Xiaoteng Ma Hongya Han Qiaoyu Shao Qiuxuan Li Source Type: research

Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India
Curr Vasc Pharmacol. 2021 Nov 9. doi: 10.2174/1570161119666211109122231. Online ahead of print.ABSTRACTStroke is the second most common cause of death worldwide. The rates of stroke are increasing in less affluent countries predominantly because of a high prevalence of modifiable risk factors. The Lipid Association of India (LAI) has provided a risk stratification algorithm for patients with ischaemic stroke and recommended low density lipoprotein cholesterol (LDL-C) goals for those in a very high risk group and extreme risk group (category A) of <50 mg/dl (1.3 mmol/l) while the LDL-C goal for extreme risk group (catego...
Source: Current Vascular Pharmacology - November 9, 2021 Category: Drugs & Pharmacology Authors: Raman Puri Vimal Mehta S S Iyengar Padma Srivastava Jamal Yusuf Akshaya Pradhan Jeyaraj Durai Pandian Vijay K Sharma P N Renjen A Muruganathan K Mugundhan A V Srinivasan Sadanand Shetty S N Narasingan Devaki R Nair Manish Bansal D Prabhakar Mukul Varma Vi Source Type: research

Clopidogrel Hypersensitivity: Overview of the Problem.
Abstract Clopidogrel is one of the most commonly prescribed drugs worldwide. It plays an essential therapeutic role in a variety of vascular conditions including acute coronary syndromes, ischemic heart disease treated with coronary stents, stroke, and peripheral vascular disease. Hypersensitivity reactions to clopidogrel are not uncommon and lead to its discontinuation in 1-2% of patients. Clopidogrel hypersensitivity is especially problematic in patients with newly implanted drug-eluting coronary stents. Premature discontinuation of dual antiplatelet therapy after recent coronary intervention is the most importa...
Source: Current Vascular Pharmacology - August 20, 2018 Category: Drugs & Pharmacology Authors: Savage MP, Fischman DL Tags: Curr Vasc Pharmacol Source Type: research